Announce Date | 04/22/2025 |
EPS Normalized Actual | $7.28 (Beat by $0.94) |
EPS GAAP Actual | $7.28 (Beat by $0.94) |
Revenue Actual | $17.963B |
Revenue Surprise | Beat by $17963M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 31.62 | 14.98 | 31.20512 | 32.31691 | 4 |
Dec 2028 | 29.32 | 16.15 | 28.62092 | 29.88195 | 6 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 7.3 | 7.3 | 17.963B | 4.28% | 17963M |
FQ4 2024 (Dec 2024) | 2.23 | 2.23 | 18.622B | -1.35% | 18622M |
FQ3 2024 (Sep 2024) | 6.83 | 6.83 | 17.104B | 1.32% | 17104M |
FQ2 2024 (Jun 2024) | 6.87 | 6.87 | 18.122B | 17.43% | 18122M |
FQ1 2024 (Mar 2024) | 6.42 | 6.42 | 17.195B | 100% | 17195M |
FQ4 2023 (Dec 2023) | 7.61 | 7.61 | 18.874B | -0.62% | 18874M |
FQ3 2023 (Sep 2023) | 6.75 | 6.75 | 16.878B | -178.43% | 16878M |
FQ2 2023 (Apr 2023) | 6.46 | 6.46 | 14.964B | 100% | 14964M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 8.74328 | -- | 8.26016 | 9.00231 | 4 |
FQ3 2027 (Sep 2027) | 8.2203 | -- | 8.00475 | 8.43805 | 3 |
FQ2 2027 (Jun 2027) | 7.84883 | -- | 7.64302 | 8.05674 | 5 |
FQ1 2027 (Mar 2027) | 7.49488 | -- | 7.29835 | 7.69341 | 3 |
FQ4 2026 (Oct 2026) | 7.46973 | -- | 7.22232 | 7.62134 | 9 |
FQ3 2026 (Jul 2026) | 7.30873 | -- | 7.06665 | 7.45707 | 9 |
FQ2 2026 (Jun 2026) | 7.52758 | -- | 7.23904 | 7.74793 | 2 |
FQ1 2026 (Mar 2026) | 7.02344 | -3.94 | 6.75423 | 7.22904 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 20.89B | -- | 20.01B | 21.37B | 7 |
FQ3 2027 (Sep 2027) | 20.28B | -- | 19.87B | 20.69B | 5 |
FQ2 2027 (Jun 2027) | 19.88B | -- | 19.48B | 20.29B | 5 |
FQ1 2027 (Mar 2027) | 19.45B | -- | 19.06B | 19.85B | 5 |
FQ4 2026 (Oct 2026) | 19.15B | -- | 18.66B | 19.45B | 10 |
FQ3 2026 (Jul 2026) | 18.82B | -- | 18.34B | 19.11B | 10 |
FQ2 2026 (Jun 2026) | 19.62B | -- | 19.04B | 20.07B | 3 |
FQ1 2026 (Mar 2026) | 18.42B | 2.48 | 17.88B | 18.84B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 7.3 | 7.3 | 100% | |
FQ4 2024 (Dec 2024) | 2.23 | 2.23 | 100% | |
FQ3 2024 (Sep 2024) | 6.83 | 6.83 | 100% | |
FQ2 2024 (Jun 2024) | 6.87 | 6.87 | 100% | |
FQ1 2024 (Mar 2024) | 6.42 | 6.42 | 100% | |
FQ4 2023 (Dec 2023) | 7.61 | 7.61 | 100% | |
FQ3 2023 (Sep 2023) | 6.75 | 6.75 | 100% | |
FQ2 2023 (Apr 2023) | 6.46 | 6.46 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $17.96B | $17963M | 100% |
FQ4 2024 (Dec 2024) | $0B | $18.62B | $18622M | 100% |
FQ3 2024 (Sep 2024) | $0B | $17.1B | $17104M | 100% |
FQ2 2024 (Jun 2024) | $0B | $18.12B | $18122M | 100% |
FQ1 2024 (Mar 2024) | $0B | $17.2B | $17195M | 100% |
FQ4 2023 (Dec 2023) | $0B | $18.87B | $18874M | 100% |
FQ3 2023 (Sep 2023) | $0B | $16.88B | $16878M | 100% |
FQ2 2023 (Apr 2023) | $0B | $14.96B | $14964M | 100% |